Krishna Institute Of Medical Sciences Ltd
NSE: KIMS · Hospital
Snapshot
Unlock Krishna Institute Of Medical Sciences Ltd's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Krishna Institute of Medical Sciences Limited is a prominent Indian healthcare provider operating under the KIMS Hospitals brand. The company offers a comprehensive range of multi-specialty medical services, including cardiac, oncological, orthopedic, and organ transplantation procedures.
Business Model
The company generates revenue by providing inpatient and outpatient medical services across its network of hospitals. It leverages a multi-specialty approach to capture diverse patient segments requiring complex surgical and diagnostic care.
Growth Outlook
Growth is driven by the expansion of specialty services and the scaling of hospital operations across India. The company continues to focus on advanced medical technologies, such as robotic sciences, to enhance clinical outcomes.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures could adversely impact profit margins.
- Talent Retention. The hospital sector faces intense competition for skilled medical professionals, including surgeons and nursing staff.
- Operational Risk. Maintaining high standards of patient care and safety is critical to avoiding reputational damage and potential litigation.
- Capital Intensity. The requirement for continuous investment in medical equipment and infrastructure expansion poses a risk to cash flow management.
Start your research today
Unlock AI insights, financials, peers and live data on Krishna Institute Of Medical Sciences Ltd and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,212 Cr
TTM · consolidated
NET PROFIT
₹194 Cr
TTM · consolidated
EPS
₹5.10
TTM · consolidated
RETURN ON EQUITY
8.9%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
9.2%
TTM · consolidated
P/E
144.4×
Q1 FY27 · consolidated
EV/EBITDA
42.3x
Q1 FY27 · consolidated
EBITDA MARGIN
20.6%
TTM · consolidated
NET PROFIT MARGIN
3.2%
Q1 FY27 · consolidated
DEBT TO EQUITY
1.4x
Q1 FY27 · consolidated
Peers · Hospital
| Company | Mkt Cap | P/E (TTM) | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Krishna Institute Of Medical Sciences LtdKIMS | ₹33,519 Cr | 144.4× | 42.27 | 30.9% | 20.6% | 8.9% | 9.2% | +7.0% |
Global Health Ltd.MEDANTA | ₹40,225 Cr | 65.6× | 38.26 | 21.3% | 23.0% | 15.0% | 17.2% | +4.0% |
Narayana Hrudayalaya Ltd.NH | ₹39,223 Cr | 43.3× | 23.27 | 57.8% | 20.5% | 20.0% | 15.4% | +0.6% |
Dr. Agarwal's Health Care LimitedAGARWALEYE | ₹15,684 Cr | 103.7× | 24.25 | — | 29.4% | 9.5% | 10.8% | -3.1% |
Rainbow Childrens Medicare LtdRAINBOW | ₹14,284 Cr | 45.5× | 23.30 | 18.3% | 33.6% | 18.6% | 18.7% | -4.7% |
Park Medi WorldPARKHOSPS | ₹12,377 Cr | — | — | — | 27.0% | — | — | — |
As of Q1 FY27
Financials
Krishna Institute Of Medical Sciences Ltd
NSE: KIMS · Hospital
Snapshot
Unlock Krishna Institute Of Medical Sciences Ltd's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Krishna Institute of Medical Sciences Limited is a prominent Indian healthcare provider operating under the KIMS Hospitals brand. The company offers a comprehensive range of multi-specialty medical services, including cardiac, oncological, orthopedic, and organ transplantation procedures.
Business Model
The company generates revenue by providing inpatient and outpatient medical services across its network of hospitals. It leverages a multi-specialty approach to capture diverse patient segments requiring complex surgical and diagnostic care.
Growth Outlook
Growth is driven by the expansion of specialty services and the scaling of hospital operations across India. The company continues to focus on advanced medical technologies, such as robotic sciences, to enhance clinical outcomes.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures could adversely impact profit margins.
- Talent Retention. The hospital sector faces intense competition for skilled medical professionals, including surgeons and nursing staff.
- Operational Risk. Maintaining high standards of patient care and safety is critical to avoiding reputational damage and potential litigation.
- Capital Intensity. The requirement for continuous investment in medical equipment and infrastructure expansion poses a risk to cash flow management.
Start your research today
Unlock AI insights, financials, peers and live data on Krishna Institute Of Medical Sciences Ltd and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,212 Cr
TTM · consolidated
NET PROFIT
₹194 Cr
TTM · consolidated
EPS
₹5.10
TTM · consolidated
RETURN ON EQUITY
8.9%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
9.2%
TTM · consolidated
P/E
144.4x
Q1 FY27 · consolidated
EV/EBITDA
42.3x
Q1 FY27 · consolidated
EBITDA MARGIN
20.6%
TTM · consolidated
NET PROFIT MARGIN
3.2%
Q1 FY27 · consolidated
DEBT TO EQUITY
1.4x
Q1 FY27 · consolidated
Peers · Hospital
As of Q1 FY27